Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Wondering what age to start retirement planning? The earlier you begin, the better prepared you'll be for a comfortable retirement.
25,085 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
A routine call became a nightmare when a scammer claimed to help with a loan. They sent mortgage payments through Wal...
A surge in AI workloads hinges on memory, and Micron’s latest signals hint at lasting strength. This piece unpacks wh...
Owens Corning stock rocked the market this week after rumor-driven buying interest and strong housing data. This guid...
The U.S. SEC has ended its enforcement action against ConsenSys over MetaMask Swaps and Staking, with no penalties an...
Stocks fell as crude jumped on renewed Middle East tensions, dragging major indices lower. Oil markets surged as trad...
Broadcom is moving deeper into AI infrastructure, signaling a shift that could influence chip design, data-center cos...
The home-improvement aisle is crowded with options, but two names stand out: Lowe's and Floor & Decor. This article b...
Tesla faces a valuation crossroads as AI-driven growth challenges traditional EV metrics. The stock trades near $412 ...
Inflation cooled in June, nudging mortgage rates higher this week. Analysts say relief could be on the horizon as the...
Broadcom is tightening its AI-driven growth narrative with a year-end price target and brisk AI silicon momentum, set...
NVIDIA announced a renewed capital-return plan that dramatically expands buybacks and raises the dividend, sending a ...